Patent and Technology License AgreementPatent and Technology License Agreement • April 14th, 2021 • Affimed N.V. • Pharmaceutical preparations
This Patent and Technology License Agreement (“Agreement”) is made on the Effective Date, by and between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas M. D. Anderson Cancer Center (“MD Anderson”), a member institution of System, and Affimed GmbH, having a principal place of business located at Im Neuenheimer Feld 582, 69120 Heidelberg, Germany (“Licensee” or “Affimed”). Board, on behalf of MD Anderson, and Licensee are each referenced herein as a “Party” and collectively as the “Parties.”
